These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6879483)

  • 1. Prognosis of cryptogenic fibrosing alveolitis.
    Tukiainen P; Taskinen E; Holsti P; Korhola O; Valle M
    Thorax; 1983 May; 38(5):349-55. PubMed ID: 6879483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.
    Turner-Warwick M; Burrows B; Johnson A
    Thorax; 1980 Aug; 35(8):593-9. PubMed ID: 7444826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.
    Rudd RM; Haslam PL; Turner-Warwick M
    Am Rev Respir Dis; 1981 Jul; 124(1):1-8. PubMed ID: 7258815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.
    Johnston ID; Gomm SA; Kalra S; Woodcock AA; Evans CC; Hind CR
    Eur Respir J; 1993 Jun; 6(6):891-3. PubMed ID: 8339811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.
    Bateman ED; Turner-Warwick M; Haslam PL; Adelmann-Grill BC
    Thorax; 1983 Feb; 38(2):93-101. PubMed ID: 6344313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse interstitial pulmonary fibrosis (cryptogenic fibrosing alveolitis).
    Kunstling TR; Goodwin RA; Des Prez RM
    South Med J; 1976 Apr; 69(4):479-84, 487. PubMed ID: 772819
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis.
    Scadding JG; Hinson KF
    Thorax; 1967 Jul; 22(4):291-304. PubMed ID: 6035793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis.
    Turner-Warwick M; Haslam PL
    Am Rev Respir Dis; 1987 Jan; 135(1):26-34. PubMed ID: 3800151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.
    Rudd RM; Prescott RJ; Chalmers JC; Johnston ID;
    Thorax; 2007 Jan; 62(1):62-6. PubMed ID: 16769717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
    Johnson MA; Kwan S; Snell NJ; Nunn AJ; Darbyshire JH; Turner-Warwick M
    Thorax; 1989 Apr; 44(4):280-8. PubMed ID: 2669218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of cryptogenic fibrosing alveolitis.
    Br Med J; 1978 Sep; 2(6141):849-50. PubMed ID: 709091
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptogenic fibrosing alveolitis.
    Chan-Yeung M; Müller NL
    Lancet; 1997 Aug; 350(9078):651-6. PubMed ID: 9288060
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features.
    Wright PH; Heard BE; Steel SJ; Turner-Warwick M
    Br J Dis Chest; 1981 Jan; 75(1):61-70. PubMed ID: 7259967
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging and therapy of cryptogenic fibrosing alveolitis.
    Turner-Warwick M
    Chest; 1986 Mar; 89(3 Suppl):148S-150S. PubMed ID: 3948577
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognosis of cryptogenic fibrosing alveolitis.
    Stack BH; Choo-Kang YF; Heard BE
    Thorax; 1972 Sep; 27(5):535-42. PubMed ID: 4538877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis.
    Jezek V; Fucik J; Michaljanic A; Jezkova L
    Bull Eur Physiopathol Respir; 1980; 16(6):711-20. PubMed ID: 7448462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.